Emerging evidence suggests that hypoxia contributes to the pathogenesis of AD through various mechanisms, including the promotion of amyloid beta (Aβ) formation, stimulation of tau hyperphosphorylation, disruption of blood–brain barrier function, and the facilitation of neuronal degeneration (Figure 1). Here, MAPT is linked to Alzheimer disease.